Package 43063-771-20

{"route": ["ORAL"], "spl_id": "2c259b01-1846-32c6-e063-6394a90a3498", "openfda": {"upc": ["0343063771211"], "unii": ["G447S0T1VC"], "rxcui": ["313564"], "spl_set_id": ["1b11361c-5444-498b-ab7c-fbad917705ae"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-771-06)", "package_ndc": "43063-771-06", "marketing_start_date": "20170608"}, {"sample": false, "description": "14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-771-14)", "package_ndc": "43063-771-14", "marketing_start_date": "20180323"}, {"sample": false, "description": "20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-771-20)", "package_ndc": "43063-771-20", "marketing_start_date": "20180326"}, {"sample": false, "description": "21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-771-21)", "package_ndc": "43063-771-21", "marketing_start_date": "20170811"}], "brand_name": "Valacyclovir", "product_id": "43063-771_2c259b01-1846-32c6-e063-6394a90a3498", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "43063-771", "generic_name": "Valacyclovir", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1 g/1"}], "application_number": "ANDA203047", "marketing_category": "ANDA", "marketing_start_date": "20150525", "listing_expiration_date": "20261231"}